|
Payors and Providers
The Issue
The worldwide healthcare industry is struggling to keep costs relating to medications and care delivery in check. The hope of providing optimal treatment resulting in improved outcomes and reductions in costs continues to be an industry focal point. Unfortunately, many of the mechanisms for realizing these goals have proven to be too costly or ineffective. In addition, lack of optimal treatment consistent with best practice protocols, adverse drug events, and inaccurate or incomplete diagnoses are still experienced by too many. PGxHealth believes that scientific advances in genomics and biomarker identification have set the stage for fundamentally improving healthcare delivery. An individual’s genetic profile will increasingly play an important role in clinical decision making as it relates to the selection of appropriate treatment for each patient. PGxHealth utilizes its expertise and infrastructure to discover genetic markers that are used to assist healthcare providers in determining the most efficacious and safe therapeutic and in some instances, an individual’s propensity for a given disease. Clinical Data is putting its advanced capabilities to work by Introducing Therapeutic Diagnostics™.
The Solution
Therapeutic Diagnostics™ are proprietary genetic tests, as a branded be PGxHealth, that utilize genetic information to determine which individuals will experience optimal benefit from specific therapies. Optimization of therapy will in turn result in the most desirable clinical outcomes for patients. With the introduction of genomic-based tests, choosing which therapeutic agent or intervention to utilize will be based on science rather than on pure economics as is often the case today. With the use of genetic tests, certain therapies may no longer be appropriate for use across a broad population but may be used only in populations defined by the presence or absence of a biomarker. Therefore, the use of market share drivers to reduce costs may no longer be viable. The new approach to clinical care that incorporates genetic tests will focus on lowering unit drug cost where possible, increasing efficacy of treatments provided to specific individuals, reducing adverse drug events, and getting patients to therapeutic goals more rapidly.
Please click below to find out more about how genetic tests will impact YOU.
|
